ByteDance has launched paid subscriptions for its AI chatbot Doubao. The move is aimed at monetizing the chatbot’s large user base.

Anthropic said the federal government lifted restrictions on its Claude Fable 5 and Mythos 5 models, ending a weekslong dispute. The announcement affects the company’s access to the models in the U.S. policy environment.

AI startup Prime Intellect closed a $130 million Series A round led by Radical Ventures at a $1 billion valuation, funding its platform that lets enterprises design and deploy customized AI agents for internal workflows and customer-facing tasks.

Mistral AI has launched OCR 4, a document‑intelligence model that provides multilingual optical character recognition with bounding boxes, block classification, and confidence scores in a single self‑hosted container.

Intel introduced new Xeon 6 E-core server CPUs optimized for high-density, cloud-native AI inference, targeting enterprises that run large fleets of lightweight AI services in their data centers.

Meta launched Muse, its image generation model, and integrated it into Meta AI, Instagram, and WhatsApp. AIBase reported that Muse supports tasks such as photo restoration, style transformations, room restyling, product photography, and surreal scene edits.

OpenAI released GPT‑Live, a voice AI system that can listen, reason, and speak simultaneously using a full‑duplex architecture, enabling natural back‑and‑forth conversations more like human speech. The assistant supports real‑time translation, web search during conversations, and

Google DeepMind has introduced three new Gemini Flash models, led by Gemini 3.6 Flash, which improves coding, knowledge work, and multimodal performance while cutting output token usage by about 17% compared to Gemini 3.5 Flash for production‑scale AI agents.

Thinking Machines, founded by former OpenAI CTO Mira Murati, launched Inkling, a 975-billion-parameter open-weight AI model that positions the company in the top tier of frontier model developers and reportedly coincided with a $2 billion seed round. The model is framed as part o

Anthropic has partnered with private equity giants Blackstone and Hellman & Friedman to launch Ode, a company that embeds Anthropic’s Claude engineers inside client organizations to build customized Claude-powered systems for enterprise workflows.[1]

Pfizer announced that its AI-driven drug discovery platform has successfully identified a novel cancer treatment candidate that is now entering Phase II clinical trials, highlighting the growing use of AI in pharmaceutical R&D and oncology drug development.[2]